J. Jankowski

J. Jankowski, J. Eksteen, I. Perry, 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

The continuing tale of cytokeratins in Barrett's mucosa: As you like it

J. Jankowski, A. Latchford, B. Eksteen, 2001, Gut.

Barrett's mucosa: remodelling by the microenvironment

J. Jankowski, R. Harrison, I. Perry, 2000, The Journal of pathology.

Gastro-oesophageal cancer: death at the junction

J. Jankowski, I. Perry, R. Harrison, 2000, BMJ : British Medical Journal.

Adenocarcinoma and Barrett's oesophagus.

J. Jankowski, 1992, Gut.

Surgery versus radical endotherapies for early cancer and high grade dysplasia in Barrett's oesophagus.

H. Barr, Rajvinder Singh, K. Ragunath, 2009, The Cochrane database of systematic reviews.

Chemoprevention of Esophageal Cancer

A. Higham, J. Jankowski, Elizabeth Ratcliffe, 2019 .

Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial.

D. Ferry, S. Dutton, J. Blazeby, 2014, The Lancet. Oncology.

Esophageal Adenocarcinoma in “Mice and Men”: Back to Basics!

S. Preston, J. Jankowski, S. Attwood, 2008, The American Journal of Gastroenterology.

Oncogenes and onco-suppressor gene in adenocarcinoma of the oesophagus.

J. Jankowski, D. Hopwood, J. Jankowski, 1992, Gut.

Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.

D. Kerr, N. Wright, S. Meltzer, 1999, The American journal of pathology.

Abnormal expression of growth regulatory factors in Barrett's oesophagus.

D. Hopwood, R. McMenemin, J. Jankowski, 1991, Clinical science.

The global cancer burden

J. Jankowski, R. Willans, 2019, Cancer Archives.

Editorial: One Small Step for Metaplasia, but One Giant Leap for Biomarkers Is Needed

A. Nicholson, J. Jankowski, 2009, The American Journal of Gastroenterology.

Chemoprevention of gastrointestinal cancer

J. Jankowski, L. Dunn, 2008, The British journal of surgery.

Squamous carcinoma of the oesophagus: continuing to challenge.

J. Jankowski, A. Chilton, 2001, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Gastrin induces proliferation in Barrettʼs metaplasia through activation of the CCK2 receptor

D. Thompson, C. Kirton, A. Varró, 2003 .

Tattooing and the risk of acquiring hepatitis C infection

J. Jankowski, B. Eksteen, 2002, BMJ.

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.

M. Thun, J. Cuzick, P. Brown, 2009, The Lancet. Oncology.

Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial

P. Moayyedi, H. Barr, C. Edwards, 2018, The Lancet.

Aspirin chemoprevention in barrett esophagus: is the risk worth the benefit?

J. Jankowski, 2012, Gastroenterology & hepatology.

Aspirin therapy for cancer: it is never too late

J. Jankowski, P. Limburg, 2011, British Journal of Cancer.

Does long term aspirin prevent cancer?

P. Moayyedi, J. Jankowski, 2010, British medical journal.

Nonsteroidal anti-inflammatories (NSAIDs) and aspirin for intestinal metaplasia of the stomach

K. Abrams, J. Jankowski, Anoop Babu, 2010 .

The Role of Drugs and Nutrition in the Prevention of Esophageal Adenocarcinoma Associated with Barrett’s Esophagus

J. Jankowski, P. Youd, 2016 .

Aspirin chemoprevention of gastrointestinal cancer in the next decade. A review of the evidence.

H. Jankowska, J. Jankowski, P. Hooper, 2010, Polskie Archiwum Medycyny Wewnetrznej.

Premalignant Lesions of the Oesophagus: Identification to Management

J. Jankowski, A. Latchford, 2005 .

Acid Suppression and Chemoprevention in Barrett’s Oesophagus

J. Jankowski, A. Raj, 2004, Digestive Diseases.

Tumour necrosis factor-alpha in Barrett's oesophagus: a potential novel mechanism of action.

S. J. Darnton, J. Jankowski, R. Harrison, 2002, Oncogene.

Reduced cadherin/catenin complex expression in celiac disease can be reproduced in vitro by cytokine stimulation.

B. Cooper, J. Hoyland, S. Sanders, 1999, Laboratory investigation; a journal of technical methods and pathology.

University of Birmingham Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus

C. Wijmenga, E. Kuipers, P. Moayyedi, 2022 .

The Evidence Base of Proton Pump Inhibitor Chemopreventative Agents in Barrett's Esophagus—The Good, The Bad, and The Flawed!

S. Leedham, J. Jankowski, 2007, The American Journal of Gastroenterology.

Evidence for hypomotility in non-ulcer dyspepsia: a prospective multifactorial study.

F. Campbell, J. Jankowski, P. Cullen, 1991, Gut.

[Breast cancer in the early stage].

R. J. Jones, M. Espié, G. Giaccone, 2012, Gan no rinsho. Japan journal of cancer clinics.

Surveillance for Barrett's oesophagus

J. Jankowski, J. Eksteen, 2001, BMJ : British Medical Journal.

Genetic versus environmental interactions in the oesophagitis-metaplasia-dysplasia-adenocarcinoma sequence (MCS) of Barrett's oesophagus.

J. Jankowski, R. Ransford, 2000, Acta gastro-enterologica Belgica.

Estimates of benefits and harms of prophylactic use of aspirin in the general population.

N. Cook, J. Cuzick, P. Brown, 2015 .

Response to Feuerstein J et al. “Systematic Analysis and Critical Appraisal of the Quality of the Scientific Evidence and Conflicts of Interest in Practice Guidelines (2005–2013) for Barrett’s Esophagus”. doi:10.1007/s10620-016-4222-2

P. Moayyedi, J. Jankowski, C. Bennett, 2016, Digestive Diseases and Sciences.

A feasibility trial of Acetic acid-targeted Biopsies versus nontargeted quadrantic biopsies during BArrett’s surveillance: the ABBA trial

H. Barr, G. Longcroft-Wheaton, P. Bhandari, 2019, Endoscopy.

A colorectal cell line with alterations in E-cadherin and epithelial biology may be an in vitro model of colitis.

J. Jankowski, T. Jones, I. Perry, 1999, Molecular pathology : MP.

Phase II trial of gefitinib (ZD1839) in advanced adenocarcinoma of the oesophagus incorporating biopsy before and after gefitinib.

D. Ferry, M. Anderson, J. Jankowski, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of gefitinib (ZD1839) in advanced adenocarcinoma of the oesophagus incorporating biopsy before and after gefitinib

D. Ferry, J. Jankowski, K. Beddows, 2004 .

Hereditary diffuse gastric cancer (HDGC)

J. Jankowski, O. Saraj, 2011 .

Does aspirin really reduce the risk of colon cancer?

P. Moayyedi, H. Barr, J. Jankowski, 2012, The Lancet.

Clinical gene analysis and manipulation: overview and applications in pathology

J. Jankowski, F. K. Bedford, 1995, Clinical molecular pathology.

In vivo analysis of gut function and disease changes in a zebrafish larvae model of inflammatory bowel disease: A feasibility study

A. Fleming, J. Jankowski, P. Goldsmith, 2010, Inflammatory bowel diseases.

Physiological and molecular analysis of acid loading mechanisms in squamous and columnar-lined esophagus.

R. Fitzgerald, G. Triadafilopoulos, P. Lao-Sirieix, 2008, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Morphological analysis of gastro‐esophageal diseases by molecular cell techniques

J. Baert, J. Jankowski, A. Viaene, 1995, Microscopy research and technique.

Secretory and absorptive activity of oesophageal epithelium: evidence of circulating mucosubstances

D. Hopwood, J. Jankowski, K. Wormsley, 2004, The Histochemical Journal.

Secretory and absorptive activity of oesophageal epithelium: evidence of circulating mucosubstances

D. Hopwood, J. Jankowski, K. Wormsley, 2004, The Histochemical Journal.

Uptake of horseradish peroxidase by human oesophageal explants over 24 h

D. Hopwood, J. Jankowski, K. Wormsley, 1991, The Histochemical Journal.

Uptake of horseradish peroxidase by oesophageal explants over 24 h human

D. Hopwood, J. Jankowski, K. Wormsley, 1991 .

Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.

D. Evans, J. Jankowski, S. McKee, 1999, Human molecular genetics.

Genetics of Gastroesophageal Cancer: Paradigms, Paradoxes, and Prognostic Utility

J. Jankowski, E. V. Robertson, 2008, The American Journal of Gastroenterology.

Cadherin adhesion in the intestinal crypt regulates morphogenesis, mitogenesis, motogenesis, and metaplasia formation.

J. Jankowski, C. Tselepis, I. Perry, 1999, Molecular pathology : MP.

Expression of epidermal growth factor, transforming growth factor alpha and their receptor in gastro-oesophageal diseases.

D. Hopwood, J. Jankowski, K. Wormsley, 1993, Digestive diseases.

Phase III Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Trial of Gefitinib versus Placebo in Esophageal Cancer Progressing after Chemotherapy, COG (Cancer Oesophagus Gefitinib)

D. Ferry, S. Dutton, R. Hubner, 2012 .

Advances in Brief An Antiapoptotic Role for Gastrin and the Gastrin / CCK-2 Receptor in Barrett ’ s Esophagus

S. Watson, P. Clarke, J. Jankowski, 2004 .

Proliferating cell nuclear antigen in oesophageal diseases; correlation with transforming growth factor alpha expression.

D. Hopwood, R. McMenemin, J. Jankowski, 1992, Gut.

Circulating free-radical markers and peptic ulcer disease

K. Wormsley, J. Belch, J. Jankowski, 1991 .

Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma.

J. Linehan, E. Sanidas, J. Jankowski, 1995, British Journal of Cancer.

Epidermal growth factor receptors in the oesophagus.

D. Hopwood, J. Jankowski, D. Sanders, 1992, Gut.

Gastro-Esophageal Reflux Disease and Bile Acids

J. de Caestecker, J. Jankowski, J. Todd, 2003, Journal of pediatric gastroenterology and nutrition.

Upregulation of the oncogene c-myc in Barrett’s adenocarcinoma: induction of c-myc by acidified bile acid in vitro

D. Wakelin, J. Jankowski, S. Attwood, 2003, Gut.

Risk Stratification for Healthcare workers during the CoViD-19 Pandemic; using demographics, co-morbid disease and clinical domain in order to assign clinical duties

A. Davies, J. Jankowski, W. Strain, 2020, medRxiv.

Gastroesophageal reflux disease and bulimia nervosa--a review of the literature.

J. Jankowski, M. Denholm, 2011, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

The effect of alginates on deoxycholic-acid-induced changes in oesophageal mucosal biology at pH 4

J. Jankowski, P. Dettmar, V. Strugala, 2007, Journal of biomaterials science. Polymer edition.

Editorial: Dissecting GI Phenotype–Genotype Relationships in GERD and Dyspepsia: An SNP Here and an SNP There!

N. Talley, J. Jankowski, 2009, The American Journal of Gastroenterology.

Preventing GI Cancer in those at Risk

J. Jankowski, N. Burch, 2012 .

Flow cytometry of oesophageal mucosal biopsies; epidermal growth factor receptor, and CD15

D. Hopwood, J. Jankowski, K. Wormsley, 1992, The Journal of pathology.

An Antiapoptotic Role for Gastrin and the Gastrin/CCK-2 Receptor in Barrett’s Esophagus

S. Watson, P. Clarke, J. Jankowski, 2004, Cancer Research.

Flow-cytometric analysis of growth-regulatory peptides and their receptors in Barrett's oesophagus and oesophageal adenocarcinoma.

D. Hopwood, J. Jankowski, K. Wormsley, 1992, Scandinavian journal of gastroenterology.

Epidermal growth factor in the oesophagus.

D. Hopwood, J. Jankowski, G. Coghill, 1992, Gut.

Gene expression in Barrett's mucosa: acute and chronic adaptive responses in the oesophagus.

J. Jankowski, 1993, Gut.

The field effect in Barrett’s esophagus: can we use it for screening and surveillance?

G. Farnham, J. Jankowski, 2013, Endoscopy.

The clonal origins of dysplasia from intestinal metaplasia in the human stomach.

T. Graham, N. Wright, S. Preston, 2011, Gastroenterology.

Acid reflux and oesophageal cancer.

A. Nicholson, J. Jankowski, 2011, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Molecular changes in the progression of Barrett’s oesophagus

J. Jankowski, E. Zagórowicz, 2007, Postgraduate Medical Journal.

Molecular biology of Barrett's cancer.

J. Jankowski, P. Atherfold, 2006, Best practice & research. Clinical gastroenterology.

Superficial Esophageal Cancer: Adenocarcinoma Related to Barrett’s Metaplasia and Adenoid Cystic Carcinoma

J. Jankowski, S. Ishaq, R. Harrison, 2002 .

The Metaplasia-Dysplasia-Carcinoma Sequence of Barrett’s Esophagus

N. Shepherd, A. Woodman, J. Jankowski, 2001 .

Barrett's metaplasia

J. Jankowski, Ian Perry, Janusz A Jankowski, 2000, The Lancet.

Glucose-6-phosphatase in normal adult human intestinal mucosa.

R. Jung, J. Jankowski, I. Waddell, 1992, Clinical science.

Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases

A. Auton, V. Vacic, B. Alipanahi, 2019, Nature Communications.

Chemoprevention of Colorectal Cancer

N. Arber, J. Jankowski, D. Das, 2007, Digestion.

Expression of cadherins and catenins in oral epithelial dysplasia and squamous cell carcinoma.

G. Landini, J. Jankowski, D. Sanders, 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Cadherin and catenin biology represent a global mechanism for epithelial cancer progression.

N. Shepherd, J. Jankowski, D. Sanders, 1997, Molecular pathology : MP.

Identification of lineage-uncommitted, long-lived, label-retaining cells in healthy human esophagus and stomach, and in metaplastic esophagus.

H. Barr, L. Looijenga, A. Nicholson, 2013, Gastroenterology.

Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west.

P. Moayyedi, D. Provenzale, J. Jankowski, 2002, Gastroenterology.

Molecular pathways in bladder cancer: Part 1

N. James, R. Bryan, J. Jankowski, 2005, BJU international.

Molecular pathways in bladder cancer: Part 2

N. James, R. Bryan, J. Jankowski, 2005, BJU international.

The role of beta-catenin signaling in the malignant potential of cystitis glandularis.

R. Bryan, J. Jankowski, D. Wallace, 2003, The Journal of urology.

Aspirin and NSAIDs; benefits and harms for the gut.

J. Jankowski, P. Thiagarajan, 2012, Best practice & research. Clinical gastroenterology.

Detection of Intestinal Metaplasia in Barrett's Esophagus: An Observational Comparator Study Suggests the Need for a Minimum of Eight Biopsies

Keith Abrams, P. Moayyedi, R. Sampliner, 2007, The American Journal of Gastroenterology.

The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria.

Michael Vieth, Ola Junghard, John Dent, 2006, Gastroenterology.

Aberrant P-cadherin expression is an early event in hyperplastic and dysplastic transformation in the colon

T. P. Pretlow, I. Talbot, J. Jankowski, 2002, Gut.

Shared Genetic Etiology of Obesity-Related Traits and Barrett's Esophagus/Adenocarcinoma: Insights from Genome-Wide Association Studies

M. Nöthen, S. Moebus, M. Vieth, 2019, Cancer Epidemiology, Biomarkers & Prevention.

Aberrant P‐cadherin expression is a feature of clonal expansion in the gastrointestinal tract associated with repair and neoplasia

J. Jankowski, D. Sanders, I. Perry, 2000, The Journal of pathology.

Sequential changes in cadherin‐catenin expression associated with the progression and heterogeneity of primary oesophageal squamous carcinoma

Janusz Jankowski, A. Casson, S. J. Darnton, 1998 .

Changes in gene structure and regulation of E-cadherin during epithelial development, differentiation, and disease.

J. Jankowski, F. K. Bedford, Y. Kim, 1997, Progress in nucleic acid research and molecular biology.

Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma

P. Moayyedi, H. Barr, C. Caldas, 2016, Gut.

Inflammation and gastrointestinal cancers

J. Jankowski, 2011 .

Endoscopic Variceal Band Ligation

R. Odze, J. Jankowski, Todd H. Baron, 2009, The American Journal of Gastroenterology.

Genetics of inflammatory bowel disease and associated cancers

I. Tomlinson, N. Wright, S. Leedham, 2006 .

Epidermal Growth Factor Receptor Kinase Domain Mutations in Esophageal and Pancreatic Adenocarcinomas

Janusz Jankowski, David Ferry, Patricia L. Harris, 2006, Clinical Cancer Research.

Differential expression of e-cadherin in normal, metaplastic and dysplastic esophageal mucosa - a putative biomarker.

M. Takeichi, P. Newham, J. Jankowski, 1994, International journal of oncology.

Guidelines for the management of oesophageal and gastric cancer

D. Cunningham, W. Allum, J. Blazeby, 2002, Gut.

From Tumor Immunology to Immunotherapy in Gastric and Esophageal Cancer

B. Melichar, D. Vrána, J. Jankowski, 2018, International journal of molecular sciences.

A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop.

Janusz Jankowski, Brian Reid, Stuart Spechler, 2004, Gastroenterology.

Approaches to Barrett's oesophagus treatment—the role of proton pump inhibitors and other interventions

P. Sharma, J. Jankowski, 2004, Alimentary pharmacology & therapeutics.

Why is there a change in patterns of GE cancer?

J. Jankowski, P. Thiagarajan, 2012, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

A comprehensive re-assessment of the association between vitamin D and cancer susceptibility using Mendelian randomization

A. Auton, V. Vacic, B. Alipanahi, 2021, Nature Communications.

Barrett's esophagus: an overview of the molecular biology.

J. Jankowski, D. Aldulaimi, 1999, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Chemoprevention in Barrett's esophagus: A pill a day?

J. Jankowski, P. Hooper, 2011, Gastrointestinal endoscopy clinics of North America.

Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett’s esophagus

Simon C. Potter, M. Pirinen, P. Donnelly, 2012, Nature Genetics.

Polymorphisms Near TBX 5 and GDF 7 Are Associated With Increased Risk for Barrett ’ s

C. Wijmenga, E. Kuipers, P. Moayyedi, 2017 .

Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor.

D. Thompson, J. Jankowski, C. Kirton, 2003, Gastroenterology.

Ectopic expression of P-Cadherin correlates with CDH 3 promoter hypomethylation in colorectal cancer and enhanced intestinal crypt fission in mice

Nikki, O. Sieber, I. Tomlinson, 2008 .

Mortality rates in patients with Barrett’s oesophagus

P. Moayyedi, N. Talley, N. Akhtar-Danesh, 2007, Alimentary pharmacology & therapeutics.

Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process.

Hugh Barr, Irving Waxman, Michael Vieth, 2012, Gastroenterology.

Aspirin in the primary prevention of vascular disease

H. Barr, J. Jankowski, S. Attwood, 2009, The Lancet.

Hypercalcaemia in rheumatoid arthritis revisited.

S. Ralston, W. Fraser, R. Sturrock, 1990, Annals of the rheumatic diseases.

Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma.

James Y. Dai, M. Nöthen, P. Moayyedi, 2020, Carcinogenesis.

Trefoil Factor Expression in a Human Model of the Early Stages of Barrett’s Esophagus

J. Jankowski, S. Griffin, L. Dunn, 2015, Digestive Diseases and Sciences.

No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study.

M. Nöthen, C. Caldas, P. Pharoah, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

A methodologic analysis of chemoprevention and cancer prevention strategies for gastrointestinal cancer

E. Hawk, J. Jankowski, 2006, Nature Clinical Practice Gastroenterology &Hepatology.

Barrett's esophagus: evolutionary insights from genomics.

J. Satsangi, J. Jankowski, 2013, Gastroenterology.

BOB CAT: a Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia

P. Malfertheiner, P. Moayyedi, V. Konda, 2015, The American Journal of Gastroenterology.

A Phase II Study of Gefitinib Monotherapy in Advanced Esophageal Adenocarcinoma: Evidence of Gene Expression, Cellular, and Clinical Response

D. Ferry, J. Jankowski, R. Harrison, 2007, Clinical Cancer Research.

Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours.

J. Jankowski, D. Sanders, J. Marsden, 1999, Molecular pathology : MP.

Transient P‐cadherin expression in radiation proctitis; a model of mucosal injury and repair

Rachel M. Brown, D. Morton, J. Jankowski, 2002, The Journal of pathology.

Detection of Intestinal Metaplasia in Barrett's Esophagus

P. Moayyedi, R. Sampliner, K. Abrams, 2007, The American Journal of Gastroenterology.

Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial.

M. Parmar, P. Rothwell, C. Patrono, 2019, The lancet. Gastroenterology & hepatology.

Estimates of benefits and harms of prophylactic use of aspirin in the general population

N. Cook, J. Cuzick, P. Brown, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

BASIC AND TRANSLATIONAL—ALIMENTARY TRACT Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett's Esophagus

E. Kuipers, P. Moayyedi, B. Reid, 2015 .

Polymorphisms Near TBX 5 and GDF 7 Are Associated With Increased Risk for Barrett ’ s Esophagus

C. Wijmenga, E. Kuipers, P. Moayyedi, 2022 .

Chemoprevention in Barrett's oesophagus.

J. Jankowski, Victoria Gordon, 2011, Best practice & research. Clinical gastroenterology.

Helicobacter pylori infection and gastric cancer.

J. Jankowski, 1991, BMJ.

RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome.

D. Bishop, D. Kelsell, V. Plagnol, 2012, American journal of human genetics.

Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer.

D. Aust, J. Ajani, M. Ychou, 2012, European journal of cancer.

Management of Barrett's Esophagus in the UK: Overtreated and Underbiopsied but Improved by the Introduction of a National Randomized Trial

P. Moayyedi, H. Barr, R. Sampliner, 2008, The American Journal of Gastroenterology.

Gastroenterology research: where now?

J. Jankowski, Jakob Jankowski, 2010, Expert review of gastroenterology & hepatology.

Endoscopic therapies for the prevention and treatment of early esophageal neoplasia

H. Barr, Rajvinder Singh, K. Ragunath, 2011, Expert review of gastroenterology & hepatology.

Barrett's Esophagus: Diagnosis, Screening, Surveillance, and Controversies.

Rajvinder Singh, K. Ragunath, J. Jankowski, 2007, Gut and liver.

Treatment of squamous cell and adenocarcinoma of the esophagus

J. Jankowski, B. Rathbone, Michael Rathbone, 2012 .

Hyperplastic polyps, serrated adenomas, and the serrated polyp neoplasia pathway

J. Jankowski, A. Watson, 2007 .

Gastroesophageal reflux disease and Barrett's oesophagus: an overview of evidence-based guidelines.

J. Jankowski, Elizabeth Ratcliffe, Janusz A Jankowski, 2019, Polish archives of internal medicine.

Barrett’s Esophagus: Pathogenesis and Prevention

A. Dhaliwal, J. Jankowski, M. McFarlane, 2017 .

Management of Barrett esophagus: a practical guide for clinicians based on the BADCAT and BoB CAT recommendations.

J. Jankowski, Jakob Jankowski, C. Bennett, 2015, Polskie Archiwum Medycyny Wewnetrznej.

Tipping the Balance: Benefits and Risks of Aspirin in Chemoprevention of Colorectal Cancer

J. Jankowski, P. Thiagarajan, 2013, Current Colorectal Cancer Reports.

British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus

P. Moayyedi, R. Fitzgerald, E. Bird-Lieberman, 2013, Gut.

Editorial: Genetics of Barrett's: The Bigger, the Better

E. El-Omar, J. Jankowski, 2012, The American Journal of Gastroenterology.

Diagnosis and management of Barrett’s oesophagus

Brendan Delaney, Hugh Barr, Janusz Jankowski, 2010, BMJ : British Medical Journal.

Improving surveillance for Barrett's oesophagus: AspECT and BOSS trials provide an evidence base

H. Barr, J. Jankowski, 2006, BMJ : British Medical Journal.

Barrett's Oesophagus Surveillance versus endoscopy at need Study (BOSS): protocol and analysis plan for a multicentre randomized controlled trial

P. Moayyedi, H. Barr, A. Briggs, 2015, Journal of medical screening.

Prevention of colorectal cancer by combining early detection and chemoprevention

J. Jankowski, D. Das, 2009 .

Comparing virtual with conventional microscopy for the consensus diagnosis of Barrett’s neoplasia in the AspECT Barrett’s chemoprevention trial pathology audit

H. Grabsch, M. Novelli, A. Bateman, 2012, Histopathology.

Chemoprevention of oesophageal cancer and the AspECT trial.

J. Jankowski, A. Chilton, D. Das, 2009, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Point

R. Hunt, J. Jankowski, 2008 .

Clinical and molecular pathology of the metaplasia–dysplasia–carcinoma sequence in Barrett's oesophagus

J. Jankowski, P. Tanière, J. Jankowski, 2003 .

Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia

P. Malfertheiner, P. Moayyedi, V. Konda, 2015, The American Journal of Gastroenterology.

Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer

R. Houlston, D. Evans, I. Tomlinson, 2002, Oncogene.

Development of Quality Indicators for Endoscopic Eradication Therapies in Barrett’s Esophagus: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett’s Esophagus) Consortium

Kenneth J. Chang, G. Ginsberg, Kenneth K Wang, 2017, The American Journal of Gastroenterology.

Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium.

Kenneth J. Chang, G. Ginsberg, Kenneth K Wang, 2016, Gastrointestinal endoscopy.

An assessment of candidate genes to assist prognosis in gastric cancer.

J. Brettschneider, D. Snead, S. James, 2018, Journal of gastrointestinal oncology.

Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagus.

H. Barr, Rajvinder Singh, K. Ragunath, 2020, The Cochrane database of systematic reviews.

Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagus.

H. Barr, Rajvinder Singh, K. Ragunath, 2012, The Cochrane database of systematic reviews.

Surgery versus radical endotherapies for early cancer and high grade dysplasia in Barrett's oesophagus.

H. Barr, Rajvinder Singh, K. Ragunath, 2010, The Cochrane database of systematic reviews.

How does Barrett ’ s oesophagus progress to adenocarcinoma of the oesophagus ?

Kenneth K Wang, H. Barr, B. Delaney, 2011 .

Growth factors and oncogenes in Barrett's oesophagus and gastric metaplasia.

J. Jankowski, M. Filipe, 1993, Endoscopy.

Barrett’s Esophagus: Environmental Influences in the Progression of Dysplasia

J. Jankowski, R. Boulton, I. Mohammed, 2003, World journal of surgery.

Optimizing Surveillance in Barrett's Esophagus: Response to Rugge et al.

P. Moayyedi, J. Jankowski, J. deCaestecker, 2008, The American Journal of Gastroenterology.

Oesophageal carcinoma: the need for screening.

J. Jankowski, K. Wormsley, R. Jankowski, 1993, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Cancer prevention

J. Jankowski, E. Boulton, 2005, British medical journal.

Chemoprevention for Barrett's Esophagus

J. Jankowski, E. Zagórowicz, 2007 .

Adenocarcinoma in Barrett Esophagus: Too Common, Too Fatal, and Still Too Badly Managed

J. Jankowski, K. Kosuri, 2007 .

Sequential changes in cadherin-catenin expression associated with the progression and heterogeneity of primary oesophageal squamous carcinoma.

A. Casson, S. J. Darnton, J. Jankowski, 1999, International journal of cancer.

Flow-cytometric assessment of regulatory peptides in Barrett's mucosa.

J. Jankowski, 1992, Gastroenterology.

Chemoprevention: can we prevent esophageal cancer?

J. Jankowski, M. Denholm, 2015 .